NCT06043323 2026-05-06A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular LymphomaM.D. Anderson Cancer CenterPhase 2 Recruiting20 enrolled